197 related articles for article (PubMed ID: 29296904)
1. Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH.
Hayden A; Lin M; Park S; Pudek M; Schneider M; Jordan MB; Mattman A; Chen LYC
Blood Adv; 2017 Dec; 1(26):2529-2534. PubMed ID: 29296904
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
Naymagon L; Tremblay D; Troy K; Mascarenhas J
Eur J Haematol; 2020 Sep; 105(3):255-261. PubMed ID: 32353917
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble interleukin-2 receptor (sIL-2R) is an accurate biomarker for dengue-associated hemophagocytic lymphohistiocytosis syndrome diagnosed by Hscore.
Mahabala C; Koushik VK; Manjrekar PA; Balanthimogru P
Infection; 2023 Apr; 51(2):433-438. PubMed ID: 35999341
[TBL] [Abstract][Full Text] [Related]
5. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
7. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T
Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
[TBL] [Abstract][Full Text] [Related]
9. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
Wieland CW; Vogl T; Ordelman A; Vloedgraven HG; Verwoolde LH; Rensen JM; Roth J; Boer J; Hessels J
Br J Dermatol; 2013 Jun; 168(6):1252-8. PubMed ID: 23320892
[TBL] [Abstract][Full Text] [Related]
10. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin 2 receptor is risk for sarcopenia in Men with high fracture risk.
Ge J; Zeng J; Li N; Ma H; Zhao Z; Sun S; Jing Y; Qian C; Fei Z; Qu S; Cui R; Sheng H
J Orthop Translat; 2023 Jan; 38():213-219. PubMed ID: 36439626
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
[TBL] [Abstract][Full Text] [Related]
13. Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.
Toji T; Takata K; Sato Y; Miyata-Takata T; Hayashi E; Habara T; Maeda Y; Tanimoto M; Yoshino T
J Clin Pathol; 2015 Aug; 68(8):622-7. PubMed ID: 25935549
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
Kuuliala A; Leirisalo-Repo M; Möttönen T; Hannonen P; Nissilä M; Kautiainen H; Korpela M; Julkunen H; Hakola M; Repo H;
Clin Exp Rheumatol; 2005; 23(2):243-6. PubMed ID: 15895898
[TBL] [Abstract][Full Text] [Related]
16. The soluble interleukin-2 receptor: biology, function, and clinical application.
Rubin LA; Nelson DL
Ann Intern Med; 1990 Oct; 113(8):619-27. PubMed ID: 2205142
[TBL] [Abstract][Full Text] [Related]
17. Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index.
Goto H; Tsurumi H; Takemura M; Ino-Shimomura Y; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Goto N; Okuno M; Takami T; Seishima M; Moriwaki H
J Cancer Res Clin Oncol; 2005 Feb; 131(2):73-9. PubMed ID: 15503137
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
Goto N; Tsurumi H; Goto H; Shimomura YI; Kasahara S; Hara T; Yasuda I; Shimizu M; Murakami N; Yoshikawa T; Fukuno K; Takahashi T; Kito Y; Takami T; Moriwaki H
Ann Hematol; 2012 May; 91(5):705-714. PubMed ID: 22183251
[TBL] [Abstract][Full Text] [Related]
19. sIL-2R: A Novel Diagnostic Biomarker for Primary Adrenal Lymphoma.
Yu K; Xie W; Zhao L; Wang H; Ren Y; Zheng C; Chen X; Su Z; Tang Y; Zhou F; Tian H; Zhu Y; Chen T
J Clin Endocrinol Metab; 2022 May; 107(6):e2284-e2290. PubMed ID: 35254444
[TBL] [Abstract][Full Text] [Related]
20. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
Schroeder TJ; Helling T; McKenna RM; Rush D; Jeffrey JR; Brewer B; Martin LA; Traylor D; Fisher RA; First MR
Transplantation; 1992 Jan; 53(1):34-40. PubMed ID: 1733082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]